Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)

Purpose: Myeloid-derived suppressor cells (MDSC) are considered an important T-cell immunosuppressive component in cancer-bearing hosts. The factors that attract these cells to the tumor microenvironment are poorly understood. IL8 (CXCL8) is a potent chemotactic factor for neutrophils and monocytes. Experimental Design: MDSC were characterized and sorted by multicolor flow cytometry on ficoll-gradient isolated blood leucokytes from healthy volunteers (n = 10) and advanced cancer patients (n = 28). In chemotaxis assays, sorted granulocytic and monocytic MDSC were tested in response to recombinant IL8, IL8 derived from cancer cell lines, and patient sera. Neutrophil extracellular traps (NETs) formation was assessed by confocal microscopy, fluorimetry, and time-lapse fluorescence confocal microscopy on short-term MDSC cultures. Results: IL8 chemoattracts both granulocytic (GrMDSC) and monocytic (MoMDSC) human MDSC. Monocytic but not granulocytic MDSC exerted a suppressor activity on the proliferation of autologous T cells isolated from the circulation of cancer patients. IL8 did not modify the T-cell suppressor activity of human MDSC. However, IL8 induced the formation of NETs in the GrMDSC subset. Conclusions: IL8 derived from tumors contributes to the chemotactic recruitment of MDSC and to their functional control. Clin Cancer Res; 22(15); 3924–36. ©2016 AACR.

[1]  Ash A. Alizadeh,et al.  Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers , 2015 .

[2]  T. Gould,et al.  Release of Neutrophil Extracellular Traps by Neutrophils Stimulated With Antiphospholipid Antibodies: A Newly Identified Mechanism of Thrombosis in the Antiphospholipid Syndrome , 2015, Arthritis & rheumatology.

[3]  A. Arina,et al.  Myeloid-derived suppressor cell impact on endogenous and adoptively transferred T cells. , 2015, Current opinion in immunology.

[4]  Je-in Youn,et al.  Regulation of tumor metastasis by myeloid-derived suppressor cells. , 2015, Annual review of medicine.

[5]  Y. Toiyama,et al.  In Vivo Characterization of Neutrophil Extracellular Traps in Various Organs of a Murine Sepsis Model , 2014, PloS one.

[6]  M. Battaglia,et al.  CXCR1/2 Inhibition Blocks and Reverses Type 1 Diabetes in Mice , 2014, Diabetes.

[7]  B. Sangro,et al.  Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins , 2014, Clinical Cancer Research.

[8]  A. Alimonti,et al.  Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer , 2014, Nature.

[9]  Jeffrey W Pollard,et al.  Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.

[10]  R. Kiessling,et al.  Myeloid-derived suppressor cells and their role in CTLA-4 blockade therapy , 2014, Cancer Immunology, Immunotherapy.

[11]  W. Nauseef,et al.  Neutrophils at work , 2014, Nature Immunology.

[12]  Amber J. Giles,et al.  Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy , 2014, Science Translational Medicine.

[13]  C. Ziegler,et al.  Computational Algorithm-Driven Evaluation of Monocytic Myeloid-Derived Suppressor Cell Frequency for Prediction of Clinical Outcomes , 2014, Cancer Immunology Research.

[14]  E. Shankar,et al.  Blockade of CXCR2 signalling: A potential therapeutic target for preventing neutrophil-mediated inflammatory diseases , 2014, Experimental biology and medicine.

[15]  D. Schadendorf,et al.  Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A–Specific T Cells , 2013, Clinical Cancer Research.

[16]  Claudia Fischbach,et al.  Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche. , 2013, Cancer research.

[17]  R. Clarke,et al.  Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells , 2013, Breast Cancer Research.

[18]  Paul Kubes,et al.  Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. , 2013, The Journal of clinical investigation.

[19]  Austin Miller,et al.  Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality. , 2013, Cancer research.

[20]  J. Prieto,et al.  Liver Gene Transfer of Interkeukin-15 Constructs That Become Part of Circulating High Density Lipoproteins for Immunotherapy , 2012, PloS one.

[21]  M. Colombo,et al.  Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity. , 2012, Blood.

[22]  E. Bonifacio,et al.  CXCR1/2 inhibition enhances pancreatic islet survival after transplantation. , 2012, The Journal of clinical investigation.

[23]  A. Zychlinsky,et al.  Neutrophil extracellular traps: Is immunity the second function of chromatin? , 2012, The Journal of cell biology.

[24]  R. Kiessling,et al.  On the armament and appearances of human myeloid-derived suppressor cells. , 2012, Clinical immunology.

[25]  B. Schilling,et al.  Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples. , 2012, Journal of immunological methods.

[26]  J. Kotyza.  Interleukin-8 (CXCL8) in Tumor Associated Non-Vascular Extracellular Fluids: Its Diagnostic and Prognostic Values. A Review , 2012, The International journal of biological markers.

[27]  D. Gabrilovich,et al.  Coordinated regulation of myeloid cells by tumours , 2012, Nature Reviews Immunology.

[28]  J. Wolchok,et al.  Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment. , 2012, Cancer research.

[29]  J. Wolchok,et al.  Monocytic CCR2+ Myeloid Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T Cell Infiltration Into the Tumor Microenvironment , 2011 .

[30]  A. Mantovani,et al.  Cancer‐promoting tumor‐associated macrophages: New vistas and open questions , 2011, European journal of immunology.

[31]  I. Melero,et al.  Carcinoma-Derived Interleukin-8 Disorients Dendritic Cell Migration Without Impairing T-Cell Stimulation , 2011, PloS one.

[32]  M. Surette,et al.  A Novel Mechanism of Rapid Nuclear Neutrophil Extracellular Trap Formation in Response to Staphylococcus aureus , 2010, The Journal of Immunology.

[33]  D. Gabrilovich,et al.  Myeloid-Derived Suppressor Cells in Human Cancer , 2010, Cancer journal.

[34]  S. Gordon,et al.  Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.

[35]  N. Ferrara.  Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis , 2010, Current opinion in hematology.

[36]  W. Nacken,et al.  Neutrophil Extracellular Traps Contain Calprotectin, a Cytosolic Protein Complex Involved in Host Defense against Candida albicans , 2009, PLoS pathogens.

[37]  S. Ugel,et al.  Therapeutic targeting of myeloid-derived suppressor cells. , 2009, Current opinion in pharmacology.

[38]  D. Waugh,et al.  The Interleukin-8 Pathway in Cancer , 2008, Clinical Cancer Research.

[39]  D. Ladant,et al.  Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system. , 2007, Cancer research.

[40]  G. Opdenakker,et al.  Murine CXCR1 Is a Functional Receptor for GCP-2/CXCL6 and Interleukin-8/CXCL8* , 2007, Journal of Biological Chemistry.

[41]  Stephen R. Clark,et al.  Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood , 2007, Nature Medicine.

[42]  Paolo Serafini,et al.  Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. , 2006, The Journal of clinical investigation.

[43]  Andrea Rosario Beccari,et al.  ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. , 2006, Pharmacology & therapeutics.

[44]  J. Prieto,et al.  Dendritic cells delivered inside human carcinomas are sequestered by interleukin‐8 , 2005, International journal of cancer.

[45]  A. Zychlinsky,et al.  Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.

[46]  S. Cingarlini,et al.  Derangement of immune responses by myeloid suppressor cells , 2004, Cancer Immunology, Immunotherapy.

[47]  M. Colombo,et al.  IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice1 , 2003, The Journal of Immunology.

[48]  K. Xie,et al.  Interleukin-8 and human cancer biology. , 2001, Cytokine & growth factor reviews.

[49]  M. Baggiolini,et al.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. , 1989, The Journal of clinical investigation.

[50]  M. Baggiolini,et al.  Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. , 1987, Biochemical and biophysical research communications.

[51]  J. Prieto,et al.  Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein. , 2013, Cancer research.

[52]  Jeremy J. W. Chen,et al.  The role of interleukin-8 in cancer cells and microenvironment interaction. , 2005, Frontiers in bioscience : a journal and virtual library.

[53]  A. S. Pak,et al.  Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.